1620 Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History
1620 Investment Advisors, Inc.
- $126 Million
- Q4 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 13,698 shares of BMY stock, worth $674,352. This represents 0.61% of its overall portfolio holdings.
Number of Shares
13,698
Previous 9,291
47.43%
Holding current value
$674,352
Previous $480,000
61.25%
% of portfolio
0.61%
Previous 0.39%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,780Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.35 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.81 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.73 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.68 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$2.97 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $105B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...